Adel Mekhail - 19 May 2023 Form 4/A - Amendment Insider Report for Prestige Consumer Healthcare Inc. (PBH)

Role
EVP, Marketing & Sales
Signature
/s/ Adel Mekhail by William P'Pool as attorney-in-fact pursuant to power of attorney dated May 14, 2019 on file with the Commission
Issuer symbol
PBH
Transactions as of
19 May 2023
Net transactions value
-$517,229
Form type
4/A - Amendment
Filing time
24 May 2023, 14:15:48 UTC
Date Of Original Report
22 May 2023
Previous filing
08 May 2023
Next filing
20 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBH Common Stock, par value $0.01 per share Options Exercise $301,900 +10,000 +54% $30.19 28,681 19 May 2023 Direct
transaction PBH Common Stock, par value $0.01 per share Sale $600,000 -10,000 -35% $60.00 18,681 19 May 2023 Direct
transaction PBH Common Stock, par value $0.01 per share Options Exercise $217,187 +7,194 +39% $30.19 25,875 19 May 2023 Direct
transaction PBH Common Stock, par value $0.01 per share Sale $436,316 -7,194 -28% $60.65 18,681 19 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -10,000 -47% $0.000000 11,194 19 May 2023 Common Stock 10,000 $30.19 Direct F2
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -7,194 -64% $0.000000 4,000 19 May 2023 Common Stock 7 $30.19 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to accurately reflect the exercise price of the options granted on May 13, 2019, which exercise price was inadvertently reported incorrectly in the original Form 4 filed on May 22, 2023. The correct exercise price is $60.65.
F2 Options vested and became exercisable on the third anniversary of the grant date.